Digging Into the Growth in 340B Contract Pharmacies
Paula Chatterjee shares new research on the whether a popular discount drug program is reaching the patients it was designed to support.
Read MorePrescription drugs
3 Studies That Show the Promise of Telemedicine Data
Ateev Mehrotra explains why a trio of studies on overprescribing antiobiotics has him excited about telemedicine data.
Read More
High-Price Drugs Out of Reach for Many on Medicare
Bianca Frogner breaks down new research on the impact subsidies can have for people on Medicare trying to access lifesaving drugs.
Read More
The Sky-High Price of Insulin and What Lawmakers Are Trying To Do About It
We explore the high cost of insulin in the U.S. and Congress’ latest push to address those prices with Kaiser Health News reporter Bram Sable-Smith.
Read More
How One Alzheimer’s Drug Is Changing the U.S. Drug Approval Conversation
Taking stock of the impact of the Aduhelm saga and Medicare’s decision to restrict coverage of the controversial treatment.
Read More
Ways to Save in Budget Busting Medicare Part B
Stacie Dusetzina shares new research showing the difference in spending on Part B drugs in Medicare and Medicare Advantage.
Read More
The FDA Super Bowl
We break down the controversial FDA user fee process and the legislative bonanza it kicks off every five years.
Read More
Medicare’s Unprecedented Alzheimer’s Drug Decision
A doctor, a patient and a former federal official weigh in on Medicare’s recent move to restrict access to a new Alzheimer’s treatment.
Read More